Amicus Therapeutics, Inc.
Amicus Therapeutics, Inc. (FOLD) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · FOLD · as of Sep 30, 2025
Ownership Breakdown
310
Institutional Holders
▲ 24 vs Q2
$2.46B
Total Inst. Value
▲ $630.73M vs Q2
314.00M
Shares Outstanding
freeFloat 99.18%
312.57M
13F Shares Held
▼ 6.92M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
FOLD largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VANGUARD GROUP INC pharmaceutical preparations | 29.53M | 9.59% | 9.59% | $232.73B | Nov 7, 2025 | ▲ 126.4K |
WELLINGTON MANAGEMENT GROUP LLP pharmaceutical preparations | 28.63M | 9.30% | 9.30% | $225.60B | Nov 14, 2025 | ▼ 495.1K |
BLACKROCK, INC. pharmaceutical preparations | 25.85M | 8.39% | 8.39% | $203.69B | Nov 12, 2025 | ▼ 1.68M |
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC pharmaceutical preparations | 15.75M | 5.11% | 5.11% | $124.10B | Nov 12, 2025 | ▲ 1.11M |
AVORO CAPITAL ADVISORS LLC pharmaceutical preparations | 15.03M | 4.88% | 4.88% | $118.40B | Nov 14, 2025 | ▼ 2.98M |
MILLENNIUM MANAGEMENT LLC pharmaceutical preparations | 11.81M | 3.83% | 3.83% | $93.06B | Nov 14, 2025 | ▲ 4.39M |
STATE STREET CORP pharmaceutical preparations | 11.56M | 3.75% | 3.75% | $91.12B | Nov 14, 2025 | ▼ 5.2K |
VESTAL POINT CAPITAL, LP pharmaceutical preparations | 9.75M | 3.17% | 3.17% | $76.83B | Nov 14, 2025 | ▼ 2.15M |
CITADEL ADVISORS LLC pharmaceutical preparations | 8.25M | 2.68% | 2.68% | $65.01B | Nov 14, 2025 | ▲ 2.28M |
POINT72 ASSET MANAGEMENT, L.P. pharmaceutical preparations | 7.16M | 2.32% | 2.32% | $56.39B | Nov 14, 2025 | ▲ 3.88M |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
23
Increased
+24.05M shares2
New Positions
first time holders24
Decreased
−23.84M shares0
Sold Out
fully exitedNet shares change (top 50)
+208.2K
+24.05M / −23.84M
Net new holders
+1
2 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
FOLD insider trading · insider activity
Source: SEC Form 4
0
Buy transactions
111
Sell transactions
0.00
Buy/Sell ratio
$10M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
WHEELER CRAIG A director | Apr 27, 2026 | D-Return | 84,631 | $14.50 | $1.23M | 0 | Form 4 ↗ |
WHEELER CRAIG A director | Apr 27, 2026 | D-Return | 30,000 | $6.71 | $201.3K | 0 | Form 4 ↗ |
WHEELER CRAIG A director | Apr 27, 2026 | D-Return | 16,236 | $8.60 | $139.6K | 0 | Form 4 ↗ |
WHEELER CRAIG A director | Apr 27, 2026 | D-Return | 19,473 | $12.00 | $233.7K | 0 | Form 4 ↗ |
WHEELER CRAIG A director | Apr 27, 2026 | D-Return | 18,574 | $12.81 | $237.9K | 0 | Form 4 ↗ |
WHEELER CRAIG A director | Apr 27, 2026 | D-Return | 36,111 | $10.71 | $386.7K | 0 | Form 4 ↗ |
WHEELER CRAIG A director | Apr 27, 2026 | D-Return | 45,423 | $8.55 | $388.4K | 0 | Form 4 ↗ |
WHEELER CRAIG A director | Apr 27, 2026 | D-Return | 30,474 | $12.62 | $384.6K | 0 | Form 4 ↗ |
WHEELER CRAIG A director | Apr 27, 2026 | D-Return | 42,467 | $10.27 | $436.1K | 0 | Form 4 ↗ |
WHEELER CRAIG A director | Apr 27, 2026 | D-Return | 74,872 | $5.96 | $446.2K | 0 | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Amicus Therapeutics, Inc. (FOLD) is primarily owned by institutional investors, who hold approximately 99.5% of total shares outstanding. Company insiders own approximately 0.82%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of Amicus Therapeutics, Inc. is VANGUARD GROUP INC, holding approximately 29.53 million shares — equal to 9.59% of outstanding shares — as of September 30, 2025.
A total of 310 institutional investors currently hold FOLD stock, with a combined institutional value of approximately $2.46 billion as of the most recent 13F filing period.
Frequently asked questions
FOLD ownershipAmicus Therapeutics, Inc. (FOLD) is primarily owned by institutional investors, who hold approximately 99.5% of shares. The largest shareholder is VANGUARD GROUP INC with a 9.59% stake. Company insiders hold 0.82%. Data sourced from SEC Form 13F as of September 30, 2025.